Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
An overwhelming volume of arbitration requests has made it difficult for providers, including labs, to quickly challenge and resolve payment disputes under the law.
Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements
Premium
After the VALID Act didn't pass, it's uncertain how the FDA will proceed, though some payors aren't waiting for the status quo to change and asking labs to submit additional validation data on cancer tests.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
White House COVID Dx Goals Potentially Feasible but More Funding, Coordination Needed, Experts Say
Premium
The timelines the administration set this fall for ramping testing in the event of a health emergency are potentially doable but largely aspirational at the moment.
Lawmakers are still wrangling over whether to include these two key lab industry bills in an end-of-year spending package due to pass next week.